Clinical Trials Browser

lortalamine × Clear all

NCT02615067 2019-04-10

proSPECT-AS

Phase 3 Completed

Disease, Prostatic Neoplasms

NCT00925275 2010-05-04

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Phase 1 Completed

Neoplasms, Recurrence